fda bpc-157 not approved warning The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link bpc 157 safety fda status

All of our peptides are verified at a minimum of 99% purity

But you've reduced effective dose by nearly half through timing alone

Each cc contains 1000 mcg

Per-Peptide HPLC and LC-MS Verification on Every Batch Pre-committed acceptance criteria for both peptides get logged before each synthesis run begins, with purity and identity scored independently for the BPC-157 fraction and the TB-500 fraction rather than against a combined chromatogram

Kuhlmann C, Mayer CK, Claassen M, Maponga T, Burgers WA, Keeton R, et al

The most commonly reported adverse events in Phase 2 and Phase 3 trials were gastrointestinal in nature, including nausea, diarrhea, vomiting, and constipation